Related Experiment Video
Updated: May 14, 2025
Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
Published on: August 23, 2018
Emodin and Aloe-Emodin Reduce Cell Growth and Disrupt Metabolic Plasticity in Human Melanoma Cells
Federica Baldassari1,2, Marcella Bonanomi1, Sara Mallia1,2
1Institute of Bioimaging and Complex Biological Systems, National Research Council (CNR), 20054 Segrate, MI, Italy.
Abstract:
Background/Objectives: Melanoma is an aggressive skin cancer with intratumor metabolic heterogeneity, which drives its progression and therapy resistance. Natural anthraquinones, such as emodin and aloe-emodin, exhibit anti-cancer properties, but their effects on metabolic plasticity remain unclear. This study evaluated their impact on proliferation and metabolic pathways in heterogenous melanoma human cell lines. Methods: COLO 800, COLO 794, and A375 melanoma cell lines representing distinct metabolic phenotypes were analyzed. Targeted and untargeted metabolomics analyses integrated with Seahorse assays were performed to assess the effects of emodin and aloe-emodin on cell proliferation, mitochondrial function, and redox homeostasis. Glucose tracing using [U-13C6] glucose and metabolic flux analysis (MFA) were carried out to evaluate the glycolysis and TCA cycle dynamics. Results: Emodin and aloe-emodin inhibited proliferation by disrupting glycolysis, oxidative phosphorylation, and energy production across all cell lines. Both compounds impaired glucose metabolism, reduced TCA cycle intermediates, and induced mitochondrial ROS accumulation, causing oxidative stress and redox imbalance. Despite intrinsic metabolic differences, COLO 800 and COLO 794 upregulated antioxidant defenses; A375 enhanced one-carbon metabolism and amino acid pathways to maintain redox balance and nucleotide biosynthesis. Conclusions: Emodin and aloe-emodin can disrupt the metabolic plasticity of melanoma cells by impairing glycolysis, mitochondrial function, and redox homeostasis. Their ability to target metabolic vulnerabilities across diverse phenotypes highlights their therapeutic potential for overcoming resistance mechanisms and advancing melanoma treatment strategies.
Insights
Emodin and aloe-emodin disrupt melanoma cell metabolism, inhibiting proliferation and energy production. These natural compounds show therapeutic potential against diverse melanoma phenotypes by targeting key metabolic pathways.
Area of Science:
- Cancer Biology
- Metabolomics
- Pharmacology
Background:
- Melanoma exhibits metabolic heterogeneity, contributing to progression and therapy resistance.
- Natural anthraquinones like emodin and aloe-emodin have anti-cancer effects, but their impact on melanoma metabolic plasticity is unknown.
Purpose of the Study:
- To evaluate the effects of emodin and aloe-emodin on melanoma cell proliferation and metabolic pathways.
- To investigate their impact on metabolic plasticity in heterogeneous melanoma cell lines.
Main Methods:
- Utilized three distinct melanoma cell lines (COLO 800, COLO 794, A375).
- Performed metabolomics, Seahorse assays, glucose tracing, and metabolic flux analysis (MFA).
- Assessed effects on cell proliferation, mitochondrial function, and redox homeostasis.
Main Results:
- Emodin and aloe-emodin inhibited proliferation by disrupting glycolysis and oxidative phosphorylation.
- Compounds impaired glucose metabolism, reduced TCA cycle intermediates, and increased mitochondrial reactive oxygen species (ROS).
- Cell lines exhibited differential adaptive responses in antioxidant and one-carbon metabolism pathways.
Conclusions:
- Emodin and aloe-emodin disrupt melanoma metabolic plasticity by impairing glycolysis, mitochondrial function, and redox homeostasis.
- These compounds target metabolic vulnerabilities across diverse melanoma phenotypes.
- Demonstrates therapeutic potential for overcoming resistance and advancing melanoma treatment.
